companydata.dkcompanydata.dk

Jazz Pharmaceuticals Denmark ApS: Financial statements 2022

CVR: 39791447

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

Jazz Pharmaceuticals Denmark ApS (CVR 39791447) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 30,364,239 and a net result of DKK 1,972,936 compared with DKK 560,263 the year before. That is an increase of 39.8% compared with the year before. Equity in the 2022 report amounted to DKK 10,161,721. The solvency ratio was 37%. The company had 16 employees in the financial year.

Gross Profit
DKK 30,364,239
Profit/Loss
DKK 1,972,936
Equity
DKK 10,161,721
Total Assets
DKK 27,479,090
Employees
16

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-30.4 mio.2 mio.10.2 mio.16
2021-21.7 mio.560 t.8.2 mio.10
2020-16.5 mio.1.5 mio.7.6 mio.14

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Jazz Pharmaceuticals Denmark ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Jazz Pharmaceuticals Denmark ApS: The 2021 annual report is outJul 11, 2022

Jazz Pharmaceuticals Denmark ApS has published its annual report for 2021. Gross profit came to DKK 21,713,525, and the net result was DKK 560,263.

Kamilla Enggaard Have joins Jazz Pharmaceuticals Denmark ApS as directorJun 30, 2022

As of June 30, 2022, Kamilla Enggaard Have is registered as director of Jazz Pharmaceuticals Denmark ApS.

About Jazz Pharmaceuticals Denmark ApS

Jazz Pharmaceuticals Denmark ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of David James Spackman and Kamilla Enggaard Have. The company is owned by Jazz Pharmaceuticals Ireland Holdings Limited. The company has 13 employees (2026). In 2025, the company reported a gross profit of DKK 41,044,332 and a net result of DKK 1,528,396 compared with DKK 1,538,214 the year before. Equity in the 2025 report amounted to DKK 13,823,507.

Source: annual report 2025, Danish Business Authority

Other financial years